Dual Therapeutics
New York, US · Founded 2013
Founders & leadership
Dual Therapeutics was founded in 2013 by Michael Ohlmeyer.
MO
Michael OhlmeyerManager
Board
BS
Baiju ShahManager
DU
David U'PrichardManager
Reported raises · per SEC filings
Form D private placements$6.4M disclosed across 1 round · 2013
▶$6.4MraisedOct 2014 · 11 investors · PharmaceuticalsRule 506(b)
▶$6.4MraisedOct 2014 · 11 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- David U'PrichardDirector
- Michael OhlmeyerDirector
- Al HawkinsPromoter
- Baiju ShahDirector, Promoter
- Offering amount
- $15.3M
- Amount sold
- $6.4M
- First sale
- Jul 2013
- Incorporated
- Limited Liability Company, Delaware, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded Dual Therapeutics?
- Dual Therapeutics was founded by Michael Ohlmeyer in 2013.
- How much funding has Dual Therapeutics raised?
- Dual Therapeutics has disclosed $6.4M raised across 1 round.
- Where is Dual Therapeutics headquartered?
- Dual Therapeutics is headquartered in New York, US.